Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biofactors ; 14(1-4): 107-14, 2001.
Article in English | MEDLINE | ID: mdl-11568447

ABSTRACT

Selenium is present in plasma and tissues in specific and non-specific forms. The experiments reported here were carried out to clarify some factors that affect these forms of the element in plasma. A selenium-replete human subject was given 400 microg of selenium daily for 28 days as selenomethionine and, in a separate experiment, as selenate. The selenomethionine raised plasma and albumin selenium concentrations. Selenate did neither. The molar ratio of methionine to selenium in albumin was approximately 8000 under basal and selenate-supplemented conditions but 2800 after selenomethionine supplementation. This demonstrates that selenium from selenomethionine, but not selenium from selenate, can be incorporated into albumin, presumably as selenomethionine in the methionine pool. Selenocysteine incorporation into albumin was studied in rats using (75)Se-selenocysteine. No evidence was obtained for incorporation of (75)Se into albumin after exogenous administration or endogenous synthesis of (75)Se-selenocysteine. Thus, selenocysteine does not appear to be incorporated non-specifically into proteins as is selenomethionine. These findings are in support of selenomethionine being a non-specific form of selenium that is metabolized as a constituent of the methionine pool and is unaffected by specific selenium metabolic processes. No evidence was found for non-specific incorporation of selenium into plasma proteins when it was administered as selenate or as selenocysteine. These forms of the element appear to be metabolized by specific selenium metabolic processes.


Subject(s)
Proteins/metabolism , Selenium Compounds/pharmacokinetics , Selenium/blood , Selenomethionine/pharmacokinetics , Adult , Animals , Humans , Kinetics , Male , Rats , Selenic Acid , Selenoproteins
2.
J Nutr ; 131(6): 1798-802, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11385070

ABSTRACT

Selenium and vitamin E deficiencies were studied as part of an evaluation of oxidant defenses in guinea pigs. Male guinea pigs (100-120 g) were fed a control diet (C) or the diet without selenium (0 Se), without vitamin E (0 E), or without either selenium or vitamin E (0 Se-0 E). Between d 30 and 35, 7 of 13 guinea pigs fed the 0 Se-0 E diet were euthanized because of severe weakness of their extremities. No guinea pigs in the other diet groups developed weakness. Guinea pigs from each group were killed on d 37. Selenium deficiency and vitamin E deficiency were verified by measurement of glutathione peroxidase and alpha-tocopherol. Creatine phophokinase (CPK) activity was greater than controls in both groups fed vitamin E-deficient diets, but the increase was greater in the 0 Se-0 E group than in the 0 E group. Muscle F(2)-isoprostanes were greater than controls in both groups fed vitamin E-deficient diets with the level in the 0 Se-0 E group greater than that in the 0 E group. Histologic muscle necrosis was severe in the 0 Se-0 E group, minimal in the 0 E group and absent from other groups. The diets used in this study induced selenium and vitamin E deficiencies in guinea pigs. The study demonstrates that combined selenium and vitamin E deficiency results in a fatal myopathy in guinea pigs that is associated with lipid peroxidation in the affected muscle. This nutritional myopathy is much more severe than the myopathy that occurs with vitamin E deficiency alone.


Subject(s)
Muscle, Skeletal/physiopathology , Muscular Diseases/etiology , Selenium/deficiency , Vitamin E Deficiency/metabolism , Animals , Body Weight , Creatine Kinase/analysis , Creatine Kinase/blood , Diet , Dinoprost/analogs & derivatives , Dinoprost/analysis , F2-Isoprostanes , Guinea Pigs , Liver/metabolism , Male , Muscular Diseases/blood , Muscular Diseases/physiopathology , Necrosis , Survival Analysis , Vitamin E/analysis , Vitamin E/blood , Vitamin E Deficiency/blood
3.
Arch Biochem Biophys ; 371(1): 29-34, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10525286

ABSTRACT

Selenomethionine has been suggested to protect against peroxynitrite by quenching it in vivo. Selenomethionine is distributed randomly in the methionine pool. Albumin and IgG were purified from plasma of a human being before and after 28 days of supplementation with 400 microg selenium/day as selenomethionine. The albumin contained 1 selenium atom, presumably as selenomethionine, per 8000 methionine residues before supplementation and 1 per 2800 after supplementation. Although this ratio suggested that selenomethionine would not have as great an effect in quenching peroxynitrite as would methionine, direct testing of the albumin and IgG fractions was carried out to assess the ability of these proteins to prevent peroxynitrite oxidation of dihydrorhodamine 123 to rhodamine 123. The ability of the albumin preparations to resist nitration of tyrosine residues was also assessed. The high-selenomethionine preparations of the proteins had no greater effect in quenching the peroxynitrite than did the normal-selenomethionine preparations. These results do not support the proposal that selenomethionine in proteins contributes to in vivo protection against peroxynitrite.


Subject(s)
Immunoglobulin G/chemistry , Nitrates/pharmacology , Oxidants/pharmacology , Selenium/pharmacokinetics , Selenomethionine , Serum Albumin/chemistry , Adult , Humans , Immunoglobulin G/drug effects , Male , Oxidation-Reduction , Serum Albumin/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...